University Clinical Research is categorized under University in Boca Raton, FL and active since 2012.
University Clinical Research was established in 2012, and today employs 1 to 4, earning Unknown per year. This is a University business, which does work in the B2C market, and is classified as a University, under code number 611310 by the NAICS.
If you are seeking more information, feel free to contact Aldo Zambrano at the company’s single location by writing to 600 South Dixie Highway # 200, Boca Raton, Florida FL 33432 or by phoning (561) 447-0614. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | University Clinical Research |
| Contact Person: | Aldo Zambrano |
| Address: | 600 South Dixie Highway # 200, Boca Raton, Florida 33432 |
| Phone Number: | (561) 447-0614 |
| Website Address: | bocaratonclinicalresearch.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | University |
| SIC Code: | 8221 |
| NAICS Code: | 611310 |
| Share This Business: |
University Clinical Research was started in 2012 to provide professional University under the SIC code 8221 and NAICS code 611310. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Aldo Zambrano for inquiries that concern University Clinical Research by calling the company number (561) 447-0614, as your correspondence is most welcome. Additionally, the physical location of the single location of University Clinical Research can be found at the coordinates 26.344008,-80.088515 as well as the street address 600 South Dixie Highway # 200 in Boca Raton, Florida 33432.
For its online presence, you may visit University Clinical Research’s website at bocaratonclinicalresearch.com and engage with its social media outlets through on Twitter and on Facebook.